| All Releases |
 |
February 17, 2012
Warner Chilcott Announces Earnings Release Date and Conference Call for Fourth Quarter and Full Year 2011 Financial Results |
 |
 |
| |
DUBLIN, Ireland, Feb. 17, 2012 (GLOBE NEWSWIRE) -- Warner Chilcott plc (Nasdaq:WCRX) today announced that it will issue its fourth quarter and full year 2011 financial results prior to the market opening on Friday, February 24, 2012.
In addition to issuing a press release, the Company will host a conference call for all interested parties on Fr... |
|
|
January 27, 2012
Warner Chilcott Announces 2012 Financial Guidance |
|
|
| |
DUBLIN, Ireland, Jan. 27, 2012 (GLOBE NEWSWIRE) -- Warner Chilcott plc (Nasdaq:WCRX) announced today its view of anticipated full year 2012 results.
Total revenue for 2012 is expected to be in the range of $2.5 to $2.6 billion. The 2012 revenue expectations reflect, among other things, the anticipated growth of the Company's promoted products i... |
|
|
January 24, 2012
Warner Chilcott Announces 2012 Financial Guidance Conference Call |
|
|
| |
DUBLIN, Ireland, Jan. 24, 2012 (GLOBE NEWSWIRE) -- Warner Chilcott plc (Nasdaq:WCRX) today announced that it will issue its 2012 financial guidance prior to the market opening on Friday, January 27, 2012.
In addition to issuing a press release, the Company will host a conference call for all interested parties on Friday, January 27, 2012 at 8:0... |
|
|
January 4, 2012
Warner Chilcott to Present at the 30th Annual J.P. Morgan Healthcare Conference |
|
|
| |
DUBLIN, Ireland, Jan. 4, 2012 (GLOBE NEWSWIRE) -- Warner Chilcott plc (Nasdaq:WCRX) today announced that its President, Europe/International and Global Marketing, Hans Van Zoonen, and its Executive Vice President and Chief Financial Officer, Paul Herendeen, are scheduled to speak at the 30th Annual J.P. Morgan Healthcare Conference on Tuesday, Janu... |
|
|
December 12, 2011
Warner Chilcott Announces Decision on Appeal of DORYX Preliminary Injunction |
|
|
| |
DUBLIN, Ireland, Dec. 12, 2011 (GLOBE NEWSWIRE) -- Warner Chilcott plc (Nasdaq:WCRX) today announced that the U.S. Court of Appeals for the Federal Circuit vacated a preliminary injunction granted by the U.S. District Court for the District of New Jersey against Mylan Inc. and its affiliate Mylan Pharmaceuticals Inc. (together "Mylan") and remanded... |
|
|
December 2, 2011
Warner Chilcott Announces Receipt of FDA Response to Citizen Petition |
|
|
| |
DUBLIN, Ireland, Dec. 2, 2011 (GLOBE NEWSWIRE) -- Warner Chilcott plc (Nasdaq:WCRX) today announced that it has received the Food and Drug Administration's ("FDA's") response to a citizen petition that it filed regarding its ASACOL and ASACOL HD products. In its petition, Warner Chilcott requested that the FDA confirm that it will require applicant... |
|
|
November 9, 2011
Warner Chilcott Announces Program to Redeem Up to $250 Million of Its Ordinary Shares |
|
|
| |
DUBLIN, Ireland, Nov. 9, 2011 (GLOBE NEWSWIRE) -- Warner Chilcott plc (Nasdaq:WCRX) today announced that its Board of Directors has authorized the redemption of up to an aggregate of $250 million of its ordinary shares (the "Redemption Program"). The Company expects to fund the Redemption Program with cash generated from operations.
The Company... |
|
|
November 4, 2011
Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2011 |
|
|
| |
DUBLIN, Ireland, Nov. 4, 2011 (GLOBE NEWSWIRE) -- Warner Chilcott plc (Nasdaq:WCRX) today announced its results for the quarter ended September 30, 2011. Our results of operations in the quarter and nine months ended September 30, 2011 as compared to the prior year periods were impacted by several important transactions. In 2011, these transactions... |
|
|
October 21, 2011
Warner Chilcott Announces Earnings Release Date and Conference Call for Third Quarter Financial Results |
|
|
| |
DUBLIN, Ireland, Oct. 21, 2011 (GLOBE NEWSWIRE) -- Warner Chilcott plc (Nasdaq:WCRX) today announced that it will issue its third quarter financial results prior to the market opening on Friday, November 4, 2011.
In addition to issuing a press release, the Company will host a conference call for all interested parties on Friday, November 4, 201... |
|
|
September 22, 2011
Warner Chilcott Announces Favorable Decision in DORYX Preliminary Injunction Proceedings |
|
|
| |
DUBLIN, Ireland, Sept. 22, 2011 (GLOBE NEWSWIRE) -- Warner Chilcott plc (Nasdaq:WCRX) today announced that the U.S. District Court for the District of New Jersey granted its motion for a preliminary injunction against Mylan Inc. and its affiliate Mylan Pharmaceuticals Inc. (together "Mylan"). The preliminary injunction prevents Mylan from launching... |
|
|
September 13, 2011
Warner Chilcott to Present at the UBS Global Life Sciences Conference |
|
|
| |
DUBLIN, Ireland, Sept. 13, 2011 (GLOBE NEWSWIRE) -- Warner Chilcott plc (Nasdaq:WCRX) today announced that its Executive Vice President and Chief Financial Officer Paul Herendeen is scheduled to speak at the UBS Global Life Sciences Conference on Monday, September 19th at 1:30 p.m. EDT.
The presentation will be simultaneously webcast at http://... |
|
|
September 6, 2011
Warner Chilcott to Present at the Morgan Stanley Global Healthcare Conference |
|
|
| |
DUBLIN, Ireland, Sept. 6, 2011 (GLOBE NEWSWIRE) -- Warner Chilcott plc (Nasdaq:WCRX) today announced that its Executive Vice President and Chief Financial Officer Paul Herendeen is scheduled to speak at the Morgan Stanley Global Healthcare Conference on Wednesday, September 14th at 1:00 p.m. EDT.
The presentation will be simultaneously webcast ... |
|
|
August 26, 2011
Warner Chilcott Announces Retirement of Corporate Development Head |
|
|
| |
DUBLIN, Ireland, Aug. 26, 2011 (GLOBE NEWSWIRE) -- Warner Chilcott plc (Nasdaq:WCRX) today announced that Anthony Bruno, the Company's Executive Vice President, Corporate Development, will retire at the end of this year. Mr. Bruno joined the Company in March 2001 as Senior Vice President, Corporate Development and General Counsel after spending 17 ... |
|
|
August 5, 2011
Warner Chilcott Reports Operating Results for the Quarter Ended June 30, 2011 |
|
|
| |
DUBLIN, Ireland, Aug. 5, 2011 (GLOBE NEWSWIRE) -- Warner Chilcott plc (Nasdaq:WCRX) today announced its results for the quarter ended June 30, 2011. As discussed more fully below, our results of operations in the quarter ended June 30, 2011 as compared to the prior year quarter were impacted by several important transactions in recent periods. In 2... |
|
|
August 5, 2011
Warner Chilcott Announces New Sales Leadership |
|
|
| |
DUBLIN, Ireland, Aug. 5, 2011 (GLOBE NEWSWIRE) -- Warner Chilcott plc (Nasdaq:WCRX) today announced that, in connection with a realignment of its sales organization, Marinus Johannes "Hans" van Zoonen will head the Company's North American sales organization effective immediately. Mr. van Zoonen joined the Company as President, Europe/International... |
|
|
July 27, 2011
Warner Chilcott Announces Earnings Release Date and Conference Call for Second Quarter Financial Results |
|
|
| |
DUBLIN, Ireland, July 27, 2011 (GLOBE NEWSWIRE) -- Warner Chilcott plc (Nasdaq:WCRX) today announced that it will issue its second quarter financial results prior to the market opening on Friday, August 5, 2011.
In addition to issuing a press release, the Company will host a conference call for all interested parties on Friday, August 5, 2011 a... |
|
|
July 26, 2011
Warner Chilcott Announces Acquisition of Patent Portfolio From AGI Therapeutics |
|
|
| |
DUBLIN, Ireland, July 26, 2011 (GLOBE NEWSWIRE) -- Warner Chilcott plc (Nasdaq:WCRX) today announced that it has completed the acquisition of a portfolio of patents from AGI Therapeutics plc for a purchase price of approximately $0.3 million.
"We are pleased to have acquired the intellectual property rights to a novel early stage product under ... |
|
|
July 15, 2011
Warner Chilcott Announces Decision in ACTONEL Arbitration |
|
|
| |
DUBLIN, Ireland, July 15, 2011 (GLOBE NEWSWIRE) -- Warner Chilcott plc (Nasdaq:WCRX) today announced that it received a decision from the arbitration panel in its previously disclosed arbitration proceeding relating to the termination date of its global collaboration agreement with Sanofi-Aventis U.S. LLC ("Sanofi"). Under the collaboration agreeme... |
|
|
June 23, 2011
Warner Chilcott Announces Changes in R&D Organization |
|
|
| |
DUBLIN, Ireland, June 23, 2011 (GLOBE NEWSWIRE) -- Warner Chilcott plc (Nasdaq:WCRX) today announced that Dr. Mahdi Fawzi, the Company's President, Research and Development, will be leaving the Company to pursue other interests. Dr. Fawzi joined the Company in October 2009 as the head of Research and Development and has overseen the group's expansi... |
|
|
June 16, 2011
Warner Chilcott to Present at the Wells Fargo Securities 2011 Healthcare Conference |
|
|
| |
DUBLIN, Ireland, June 16, 2011 (GLOBE NEWSWIRE) -- Warner Chilcott plc (Nasdaq:WCRX) today announced that its Executive Vice President and Chief Financial Officer Paul Herendeen is scheduled to speak at the Wells Fargo Securities 2011 Healthcare Conference on Wednesday, June 22nd at 10:15 a.m. EDT.
The presentation will be simultaneously webcas... |
|
|
|
Investor Relations
